Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

Condition:   Anemia; Hemodialysis Dependent Chronic Kidney Disease Intervention:   Drug: MT-6548 Sponsor:   Mitsubishi Tanabe Pharma Corporation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials